In silico & in vitro approaches suggest osteoclastogenesis induction underlying fractures in Entrectinib-treated children
Arch Toxicol. 2025 Jun 25. doi: 10.1007/s00204-025-04111-2. Online ahead of print. ABSTRACT Entrectinib, a potent, CNS-active, TRK and ROS1 inhibitor is associated with occurrence of …